INVESTIGATIONAL CHOLESTEROL TREATMENT PROVIDES SIGNIFICANTLY GREATER REDUCTIONS IN LDL (BAD) CHOLESTEROL COMPARED TO LIPITO...

June 28, 2006

ligrams with simvastatin 20 milligrams, the LDL reduction seen in these patients increased to 50 percent compared to 37 percent for Lipitor(R) (atorvastatin)10 milligram alone. Ezetimibe, known as ZETIA, and simvastatin, known as Zocor(R), are the 2 active ingredients in VYTORIN. A new drug application for VYTORIN, from Merck/Schering-Plough pharmaceuticals, was filed on September 17, 2003 and is currently under review by the Food and Drug Administration.